MRC Technology and Arthritis Research UK have announced a joint ‘call for targets’. The call aims to identify and fund projects focused on validation of potential small molecule or antibody targets in ...

Tech transfer organization MRC Technology negotiated a license allowing Bio-Techne to develop reagent products using a protein synthesis technology, Genetically encoded Orthogonal Protection and ...

MRC Technology (UK) announced that it has entered into an agreement with Genentech, Inc., a wholly owned member of the Roche Group for an exclusive license to a series of small molecule drug ...

London, UK, 10 October 2013: MRC Technology, a technology transfer organisation, announced today it is collaborating with Boston University to develop an anti-IL-16 antibody for use in treatment of ...

Centre for Therapeutic Discovery says deal represents first major license with industrial partner. MRC Technology granted Genentech an exclusive license to a series of small molecule drug candidates ...

London and Oxford, UK, 14 November 2013: MRC Technology, a technology transfer organisation, announced today it is collaborating with Dr Zameel Cader at Oxford University's Nuffield Department of ...

March 20, 2007, 7:11 AM UTC / Source: GlobeNewswire MARTINSRIED, Germany, March 20, 2007 (PRIME NEWSWIRE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment:TecDAX) today announced that its ...

MINNEAPOLIS, Minn., Aug. 31, 2011 /PRNewswire-iReach/ — Medibotics' U.S. patent 7,980,141 for Motion Recognition Clothing™ (MRC) has been approved. MRC is an innovative technology for translating body ...